Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model
- 28 January 2021
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1757, 147296
- https://doi.org/10.1016/j.brainres.2021.147296
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
This publication has 46 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain AgingNeuron, 2010
- BDNF-Hypersecreting Human Mesenchymal Stem Cells Promote Functional Recovery, Axonal Sprouting, and Protection of Corticospinal Neurons after Spinal Cord InjuryJournal of Neuroscience, 2009
- Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cellsJCI Insight, 2009
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degenerationNature Neuroscience, 2008
- Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALSPLOS ONE, 2007
- GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALSPLOS ONE, 2007
- Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cellsBrain Research, 2006
- Green Fluorescent Protein-Transgenic Rat: A Tool for Organ Transplantation ResearchBiochemical and Biophysical Research Communications, 2001
- Neuroprotective Utility and Neurotrophic Action of Neurturin in Postnatal Motor Neurons: Comparison with GDNF and PersephinMolecular and Cellular Neuroscience, 1999